Clinical trial
Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple…
NCT00324506 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00324506 |
|---|---|
| Title | Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis |
| Official title | A Randomized, Open-label, Parallel-Group Multicenter Study to Determine the Safety/Efficacy of Mycophenolate Mofetil in Mono & Combination Therapy With Interferon Beta 1a in Patients With Relapsing Remitting Multiple Sclerosis |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | Aspreva Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Mycophenolate Mofetil (CellCept) |
| Enrollment | 43 |
| Start date | May 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | May 11, 2006 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: